Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01758484 · ClinicalTrials.gov registry record · NA
Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant
A NA study of Hematopoietic/Lymphoid Cancer, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01758484: Completed NA study of Hematopoietic/Lymphoid Cancer, sponsored by Fred Hutchinson Cancer Center.
NCT01758484 is a NA study of Hematopoietic/Lymphoid Cancer that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 20 participants, below the 152-participant average among 4 other Hematopoietic/Lymphoid Cancer trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01758484, a NA study of Hematopoietic/Lymphoid Cancer, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot clinical trial studies supportive care for patients with hematological malignancies undergoing hematopoietic cell transplant. Supportive care may improve quality of life in this patient population.
Primary Outcome
Will mainly be descriptive.
Conditions Studied
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- OTHER palliative care
Study Locations (1)
Washington
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-04 |
| Phase | NA |
What the finished NCT01758484 record still lists
NCT01758484 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 152-participant average among 4 other Hematopoietic/Lymphoid Cancer trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Hematopoietic/Lymphoid Cancer appearing as the primary indexed condition, and to 3 interventions - of which questionnaire administration is the first listed.
NCT01758484 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01758484 about?
NCT01758484 is a clinical study titled "Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant". This pilot clinical trial studies supportive care for patients with hematological malignancies undergoing hematopoietic cell transplant. Supportive care may improve quality of life in this patient population.
What is the current status of trial NCT01758484?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-04.
What conditions does trial NCT01758484 study?
This clinical trial studies the following conditions: Hematopoietic/Lymphoid Cancer.
What interventions are being tested in trial NCT01758484?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), palliative care (OTHER).
Who is sponsoring clinical trial NCT01758484?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01758484 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematopoietic/Lymphoid Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
ACTIVE NOT RECRUITING
-
First-in-Human Study of ICT01 in Patients With Advanced Cancer
ACTIVE NOT RECRUITING · Phase 1
-
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
COMPLETED · Phase 2
-
Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia